US Patent 11254672 Dihydrobenzimidazolones for medical treatment
Patent 11254672 was granted and assigned to C4 Therapeutics on February, 2022 by the United States Patent and Trademark Office.
All edits
Edits on 18 Sep, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 31 Jul, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
0
Edits on 13 Dec, 2023
Golden AI
Edits made to:
Article (+351 characters)
Article
Patent abstract
The present invention provides selected dihydrobenzimidazolones which bind to the ubiquitously expressed E3 ligase protein cereblon (CRBN) and alter the substrate specificity of the CRBN E3 ubiquitin ligase complex, resulting in breakdown of intrinsic downstream proteins. The disclosed compounds are useful for the treatment of cancer.
Edits on 1 Nov, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 16 Oct, 2023
Golden AI
Edits made to:
Infobox (+4 properties)
Infobox
Patent Inventor Names
Annick Goergler0
Eric Andre Kusznir0
Fabian Dey0
Roger Norcross0
Edits on 18 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 26 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
112546720
Date of Patent
February 22, 2022
0Patent Application Number
168093250
Date Filed
March 4, 2020
0Official Website
Patent Primary Examiner
Edits on 6 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 23 Feb, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 11254672 Dihydrobenzimidazolones for medical treatment
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
11254672
Date of patent
February 22, 2022
Patent application number
16809325
Date Filed
March 4, 2020
Patent primary examiner
Find more entities like US Patent 11254672 Dihydrobenzimidazolones for medical treatment
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
